PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application
Y Su, B Zhang, R Sun, W Liu, Q Zhu, X Zhang… - Drug …, 2021 - Taylor & Francis
Biodegradable microspheres have been widely used in the field of medicine due to their
ability to deliver drug molecules of various properties through multiple pathways and their …
ability to deliver drug molecules of various properties through multiple pathways and their …
[HTML][HTML] Integrated gradient tissue-engineered osteochondral scaffolds: Challenges, current efforts and future perspectives
X Niu, N Li, Z Du, X Li - Bioactive Materials, 2023 - Elsevier
The osteochondral defect repair has been most extensively studied due to the rising
demand for new therapies to diseases such as osteoarthritis. Tissue engineering has been …
demand for new therapies to diseases such as osteoarthritis. Tissue engineering has been …
Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems
VS Madamsetty, R Mohammadinejad… - ACS biomaterials …, 2022 - ACS Publications
Dexamethasone (DEX) has been widely used to treat a variety of diseases, including
autoimmune diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19 …
autoimmune diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19 …
Hydrogel composite scaffolds achieve recruitment and chondrogenesis in cartilage tissue engineering applications
Background The regeneration and repair of articular cartilage remains a major challenge for
clinicians and scientists due to the poor intrinsic healing of this tissue. Since cartilage …
clinicians and scientists due to the poor intrinsic healing of this tissue. Since cartilage …
Microcarriers in application for cartilage tissue engineering: Recent progress and challenges
Successful regeneration of cartilage tissue at a clinical scale has been a tremendous
challenge in the past decades. Microcarriers (MCs), usually used for cell and drug delivery …
challenge in the past decades. Microcarriers (MCs), usually used for cell and drug delivery …
[HTML][HTML] Recent development in multizonal scaffolds for osteochondral regeneration
L Yu, S Cavelier, B Hannon, M Wei - Bioactive Materials, 2023 - Elsevier
Osteochondral (OC) repair is an extremely challenging topic due to the complex biphasic
structure and poor intrinsic regenerative capability of natural osteochondral tissue. In …
structure and poor intrinsic regenerative capability of natural osteochondral tissue. In …
Chitosan hydrogel as tissue engineering scaffolds for vascular regeneration applications
Q Wang, X Wang, Y Feng - Gels, 2023 - mdpi.com
Chitosan hydrogels have a wide range of applications in tissue engineering scaffolds,
mainly due to the advantages of their chemical and physical properties. This review focuses …
mainly due to the advantages of their chemical and physical properties. This review focuses …
Endothelial cell-targeting, ROS-ultrasensitive drug/siRNA co-delivery nanocomplexes mitigate early-stage neutrophil recruitment for the anti-inflammatory treatment of …
M Hou, X Wu, Z Zhao, Q Deng, Y Chen, L Yin - Acta Biomaterialia, 2022 - Elsevier
Neutrophils serve as a key contributor to the pathophysiology of myocardial ischemia
reperfusion injury (MIRI), because the unregulated activation and infiltration of neutrophils …
reperfusion injury (MIRI), because the unregulated activation and infiltration of neutrophils …
Intra-articular drug delivery for osteoarthritis treatment
Y Cao, Y Ma, Y Tao, W Lin, P Wang - Pharmaceutics, 2021 - mdpi.com
Osteoarthritis (OA) is the most prevalent degenerative joint disease affecting millions of
people worldwide. Currently, clinical nonsurgical treatments of OA are only limited to pain …
people worldwide. Currently, clinical nonsurgical treatments of OA are only limited to pain …
Knee osteoarthritis therapy: recent advances in intra-articular drug delivery systems
L Ma, X Zheng, R Lin, ARJ Sun, J Song… - Drug design …, 2023 - Taylor & Francis
Drug delivery for osteoarthritis (OA) treatment is a continuous challenge because of their
poor bioavailability and rapid clearance in joints. Intra-articular (IA) drug delivery is a …
poor bioavailability and rapid clearance in joints. Intra-articular (IA) drug delivery is a …